BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20442732)

  • 1. Infection: How should classic Whipple disease be managed?
    Fenollar F; Raoult D
    Nat Rev Gastroenterol Hepatol; 2010 May; 7(5):246-8. PubMed ID: 20442732
    [No Abstract]   [Full Text] [Related]  

  • 2. IV or not IV? Just one of the antibiotic questions in Whipple's disease.
    Sears CL; Cosgrove SE
    Gastroenterology; 2010 Feb; 138(2):422-6. PubMed ID: 20034604
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease.
    Feurle GE; Moos V; Bläker H; Loddenkemper C; Moter A; Stroux A; Marth T; Schneider T
    J Infect; 2013 Mar; 66(3):263-70. PubMed ID: 23291038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.
    Feurle GE; Junga NS; Marth T
    Gastroenterology; 2010 Feb; 138(2):478-86; quiz 11-2. PubMed ID: 19879276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole.
    Feurle GE; Moos V; Schneider T; Fenollar F; Raoult D
    J Antimicrob Chemother; 2012 May; 67(5):1295-6. PubMed ID: 22287233
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral optic disc swelling in Whipple's disease.
    Chiu M; Moore S
    Clin Exp Ophthalmol; 2017 Aug; 45(6):641-643. PubMed ID: 28205293
    [No Abstract]   [Full Text] [Related]  

  • 7. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro.
    Fenollar F; Perreal C; Raoult D
    Int J Antimicrob Agents; 2014 Apr; 43(4):388-90. PubMed ID: 24613421
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
    Lagier JC; Fenollar F; Lepidi H; Raoult D
    J Antimicrob Chemother; 2010 Sep; 65(9):2005-12. PubMed ID: 20639526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropheryma whipplei Infection (Whipple Disease) in the USA.
    Hujoel IA; Johnson DH; Lebwohl B; Leffler D; Kupfer S; Wu TT; Murray JA; Rubio-Tapia A
    Dig Dis Sci; 2019 Jan; 64(1):213-223. PubMed ID: 29572616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of classic Whipple's disease: from in vitro results to clinical outcome.
    Lagier JC; Fenollar F; Lepidi H; Giorgi R; Million M; Raoult D
    J Antimicrob Chemother; 2014 Jan; 69(1):219-27. PubMed ID: 23946319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A juvenile, misdiagnosed case of Whipple's disease.
    De Francesco V; Zullo A; Cristofari F; Zotti M; Stoppino G; D'Agnessa MR; Castriota M; Ierardi E
    Rheumatol Int; 2009 Nov; 30(1):143-4. PubMed ID: 19533140
    [No Abstract]   [Full Text] [Related]  

  • 12. Tropheryma whipplei endocarditis relapses after treatment with trimethoprim/sulfamethoxazole.
    Fenollar F; Lagier JC; Rolain JM; Célard M; Bouchot O; Eicher JC; Lepidi H; Raoult D
    Int J Antimicrob Agents; 2013 Jun; 41(6):592-4. PubMed ID: 23507410
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline.
    Emonet S; Wuillemin T; Harbarth S; Wassilew N; Cikirikcioglu M; Schrenzel J; Lagier JC; Raoult D; van Delden C
    Int J Infect Dis; 2015 Jan; 30():17-9. PubMed ID: 25461667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.
    Lagier JC; Fenollar F; Lepidi H; Raoult D
    J Antimicrob Chemother; 2011 May; 66(5):1188-9. PubMed ID: 21393129
    [No Abstract]   [Full Text] [Related]  

  • 15. [Whipple's disease].
    Puéchal X
    Rev Med Interne; 2009 Mar; 30(3):233-41. PubMed ID: 18722696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of diagnosis and therapy of Whipple's disease].
    Scharnke W; Dancygier H
    Dtsch Med Wochenschr; 2002 Mar; 127(9):466. PubMed ID: 11902134
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurologically presenting Whipple disease: case report and review of the literature.
    Buckle MJ; Ellis RW; Bone M; Lockman H
    J Clin Pathol; 2008 Oct; 61(10):1140-1. PubMed ID: 18381382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relapse in Whipple's disease despite maintenance therapy.
    Garas G; Cheng WS; Abrugiato R; Forbes GM
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1223-6. PubMed ID: 11106107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
    Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
    J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the best therapy for Whipple's disease? Our point of view.
    Biagi F; Biagi GL; Corazza GR
    Scand J Gastroenterol; 2017 Apr; 52(4):465-466. PubMed ID: 27924649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.